MS Is a Pain, and Doctors Should Know It
Dear Doctor, Why is it that you, or at least some of your colleagues, think that multiple sclerosis isn’t painful?…
Articles by Ed Tobias
MS News that Caught My Eye Last Week: Lemtrada Satisfaction, Limiting Tysabri’s PML Risk, MS and Pregnancy, Infusions vs. Pills
#AANAM – RRMS Patients Switching to Lemtrada Report Greater Satisfaction with Treatment and Improvements in Quality of Life I’m…
Diets and Supplements: Do They Really Help Your MS?
When I read online posts from people who treat their multiple sclerosis (MS) with vitamins and supplements, I wonder how…
MS Meds Lead the Pack as Costs of Neuro Medications Rise
Ouch! The out-of-pocket cash that people with multiple sclerosis (MS) lay out for their medications increased 20-fold between 2004 and…
MS News that Caught My Eye Last Week: Sexual Problems in Women with MS; Aubagio Satisfaction; Cellular Aging and PPMS
Women with MS Have Higher Prevalence of Sexual Dysfunction, Study Reveals I’m surprised that someone felt it necessary to…
A Judge Takes a Swing at an Insurance Company’s Denials
Robert Scola Jr. is a federal judge in Miami, and he’s just recused himself from a case involving the…
Lemtrada Risks vs. Rewards: Putting the Latest Side Effect Concerns into Perspective
There’s been a lot of social media chatter following the recent decision by the European Medicines Agency (EMA) to initiate a…
MS News that Caught My Eye Last Week: Tai Chi Study, Lemtrada Safety Review, Personalized Treatment, Online Depression Therapy
Study Will Explore Benefits of Tai Chi, Meditation on MS Patients’ Balance I’ve tried yoga to help with my…
Is It OK for Your Doctor to Hug You?
Former Vice President Joe Biden has been in some hot water recently because of his habit of hugging some…
Are Medical Mouse Studies Worth Reporting?
People who cover medical issues often write about mouse studies. These stories can regularly be found on traditional news outlets,…
Cancer Medication Shows Promise in Treating Dangerous Brain Infection PML, Small-scale Study Finds
Progressive multifocal leukoencephalopathy, more commonly referred to as PML, is a brain infection that’s frequently fatal. PML is particularly…
MS News that Caught My Eye Last Week: MS Misdiagnoses, Mineral Intake Risk Study, Hormonal Changes, Rituximab and Vitamin D
MS Misdiagnosis Too Common, Puts Patients in Unnecessary Peril from Therapies, Study Reveals Many people who have…
Immunocompromised? Watch Out for the C. Auris Fungus.
Most healthy people probably don’t have to worry about a fungus called Candida auris, or simply C. auris. But…
3 Strategies for Dealing with the High Costs of Medications
It’s tough paying for medications. Whether they’re for multiple sclerosis (MS) or another illness, Americans are having a…
MS News that Caught My Eye Last Week: Mayzent Approval Surprises, Myelin Repair, Monitoring Nerve Inflammation
Cleveland Clinic Neurologist Applauds Mayzent’s FDA Approval, But Surprised by Those It May Not Treat When I…
Mayzent Joins the MS Medication Arsenal, But I Have Questions
As you might have heard, a disease-modifying therapy (DMT) for patients with active secondary progressive multiple sclerosis (SPMS) was…
MS News that Caught My Eye Last Week: Reaction to SPMS DMT Approval, Ozanimod’s FDA Application, Caregiving Partnerships, a New Preventive Medication?
MS Patient Groups React Favorably to Mayzent Approval, But Question Therapy’s Price Tag The approval of this medication is…
Some Thoughts About Controlling Your MS Bladder
There are two types of people with MS: Those who have bladder problems and those who will have them.
MS News that Caught My Eye Last Week: Walking Med Trial Recruiting, DMT Risk Tolerance, Sex and MS
Phase 3 Trial of ADS-5102 Recruiting Participants of All MS Types This medication is similar to Ampyra (dalfampridine) because…
Things to Know If You’re Thinking About Leaving Your Neurologist
If you’re a member of the baby boomer generation, or if you just like the music of the 1960s and…
DMT Choice for Your MS Is Your Decision
About 15 disease-modifying therapies (DMTs) are available to treat MS these days. So, choosing which to use can be…
MS News that Caught My Eye Last Week: Non-contrast MRIs, Stem Cell Study Seeks Subjects, Postpartum Relapses, Which DMT?
Non-contrast MRI Effective in Monitoring Progression of MS, Study Shows There’s been increased interest in the risks…
Pediatric MS Can Be ‘Diagnostic Odyssey’
A post in one of the MS social media groups I follow recently asked whether kids can have MS.
Are MS Patients Using Too Many Medications?
Have you ever heard of the word “polypharmacy”? I saw the word for the first time today. It’s generally…
MS News that Caught My Eye Last Week: A Cure for MS?, MS App, Robot for Balance, Botox for Spasticity
All of the stories in this week’s column come from the recently held Americas Committee for Treatment…
Things Your Doctor Didn’t Tell You About Living with MS
A recent article in The New York Times hit the nail on the head when it comes to describing…
Two Different Approaches to Providing Online MS Help
I received an email recently from the National Multiple Sclerosis Society in the U.S. promoting a searchable database…
MS News that Caught My Eye Last Week: New DMT, Stem Cell Trial, Pediatric MS Treatment Study
FDA Will Review New Drug Application of Diroximel Fumarate for Relapsing Forms of MS The good news:…
Bravo to Selma Blair and Her Cane for Appearing at the Oscars
Over the past few months, I’ve had a few things to say about actress Selma Blair and the…
A Warning About ‘Young Plasma’ Treatments for Multiple Sclerosis
Plasma is the fluid part of our blood that carries nutrients and blood cells through our bodies. Donated…